Use of recombinant activated factor VII (Novoseven) in trauma and surgery: Analysis of outcomes reported to an international registry

Abstrakt

Blood loss was markedly reduced in 93.0% patients, and transfusion requirements decreased after recombinant activated factor VII administration. Mortality rate in trauma patients who had massive hemorrhage was significantly reduced.